Abstract
The long-term consequences of COVID-19 infection are becoming increasingly evident in recent studies. This repeated cross-sectional study aimed to explore the long-term health and cognitive effects of COVID-19, focusing on how virus variants, vaccination, illness severity, and time since infection impact post-COVID-19 outcomes. We examined three cohorts of university students (N=584) and used non-parametric methods to assess correlations of various health and cognitive variables with SARS-CoV-2 infection, COVID-19 severity, vaccination status, time since infection, time since vaccination, and virus variants. Our results show that some health and cognitive impairments persist, with some even progressively worsening especially fatigue in women and memory in men, up to four years post-infection, with the Wuhan variant having the most significant long-term impact and the Omicron variant the least. Interestingly, the severity of the acute illness was not correlated with the variant of SARS-CoV-2. The analysis also revealed that individuals who contracted COVID-19 after vaccination had better health and cognitive outcomes compared to those infected before vaccination. The study also discusses some limitations inherent in cross-sectional studies, particularly those arising from the stronger tendency of individuals with poorer health, compared to healthier individuals, to avoid infection and prioritize vaccination. To mitigate potential bias, the study proposes focusing on factors such as illness severity and time since infection or vaccination when analyzing persistent symptoms.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by the Czech Science Foundation, grant number 22-20785S.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Board of the Faculty of Science at Charles University gave ethical approval for this work (No. 2021/19)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced are available online at Figshare 10.6084/m9.figshare.27618876
